TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 15.00
+0.05 (0.33%)
May 29, 2026, 1:45 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 1.68 billion as of May 29, 2026. Its market cap has decreased by -39.17% in one year.
Market Cap
1.68B
Enterprise Value
1.35B
Revenue
27.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.00
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 1.68B, a decrease of -48.26%. That is a compound annual growth rate of -7.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.68B | -30.62% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunny Pharmtech | 2.07B |
| G&E Herbal Biotechnology | 2.02B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.98B |
| Greenyn Biotechnology | 1.81B |
| Synbio Tech | 1.72B |
| Anti-Microbial Savior BioteQ | 1.66B |
| Great Novel Therapeutics Biotech & Medicals | 1.64B |
| Advagene Biopharma | 1.53B |